Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0GCHQJ)
| ADC Name |
PF-08046033
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
PF-08046033
Click to Show/Hide
|
|||||
| Organization |
Pfizer (Top20 MNC) (Originator)
|
|||||
| Drug Status |
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
HCR011
|
Antibody Info | ||||
| Antigen Name |
Transmembrane glycoprotein NMB (GPNMB)
|
Antigen Info | ||||
| Payload Name |
Auristatin S
|
Payload Info | ||||
| Payload Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC